Psychiatry & Neurology Doctors in Stoneham, MA Accepting Medicare

6 Psychiatry & Neurology doctors found. Showing 1 - 6

Farrokh Khajavi-noori, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 3 Woodland Rd Ste 418, Ste 418, Stoneham, MA 02180 Phone: 781-662-6213    Fax: 781-665-9860

Dr. Sangeeta Banerjee, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 92 Montvale Ave, Suite 2450, Stoneham, MA 02180 Phone: 781-646-0500    Fax: 781-646-7130

David Binder, M.D. Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Medicare Enrolled Practice Location: 271 Main St, Suite 205, Stoneham, MA 02180 Phone: 781-438-5550    Fax: 781-438-5553

Dr. Smita Patel, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 92 Montvale Ave, Suite 2200 , Smita Patel, M.d. And Assoc., Stoneham, MA 02180 Phone: 781-438-4300    Fax: 781-279-2078

Fereydoun Shahrokhi, MD Psychiatry & Neurology - Neurology Medicare: Not Enrolled in Medicare Practice Location: 3 Woodland Road, Suite #200, Stoneham, MA 02180 Phone: 781-662-9001    Fax: 781-662-3888

Dr. Alice X Truong, M.D. Psychiatry & Neurology - Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 3 Woodland Rd, Suite 322, Stoneham, MA 02180 Phone: 781-662-2243    Fax: 781-662-4878

News Archive

Researchers identify genetic mutation for Uner Tan Syndrome

A team of researchers from leading universities in Turkey and the United States have reported that they have identified the genetic mutation responsible for the Uner Tan Syndrome (UTS) using advanced genetic capture and sequencing technologies from Roche. The combined genomic technologies enabled the team of scientists to identify the causative mutation of this debilitating disease after years of mystery.

Preclinical data on Selecta's novel immune tolerance platform published in Nature Nanotechnology

Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company developing targeted antigen-specific immune therapies for rare and serious diseases, announced today that Nature Nanotechnology has published an article that presents preclinical results from Selecta's research which demonstrate the broad potential applicability of Selecta's novel immune tolerance platform.

Study shows that obesity is up, as is drinking by women

With the time for New Year's resolutions uncomfortably close, latest data from a huge nationwide study shows that obesity is up, as is drinking by women. We are also getting more depressed and anxious and taking more drugs, and the poorer we are, the more likely it is we will smoke and not exercise or eat healthily.

Salk team uses new model to study health effects of AMP-activated protein kinase

The metabolic protein AMPK has been described as a kind of magic bullet for health. Studies in animal models have shown that compounds that activate the protein have health-promoting effects to reverse diabetes, improve cardiovascular health, treat mitochondrial disease-even extend life span.

Metabolite may predict cancer versus autism risk in PTEN patients

In a new study published in American Journal of Human Genetics, a team of researchers led by Charis Eng, M.D., Ph.D., Chair of Cleveland Clinic's Genomic Medicine Institute, identified a metabolite that may predict whether individuals with PTEN mutations will develop cancer or autism spectrum disorder.

Read more Medical News

› Verified 7 days ago